The role of pulmonary veins in atrial fibrillation: A complex yet simple story

Pharmacology and Therapeutics

Volumn 124, Issue 2, 2009, Pages 207-218

  Chard, Marisa ^a   Tabrizchi, Reza ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

arrhythmias; atria pulmonary vein junction electrophysiology; hybrid therapy; myocardial sleeves; pressure; volume

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; AMIODARONE; ANTIARRHYTHMIC AGENT; GADOLINIUM; LOSARTAN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PILSICAINIDE; PLACEBO; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; RANOLAZINE; RDS 1235; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; STREPTOMYCIN; UNCLASSIFIED DRUG; VERAPAMIL; VERNAKALANT;

CELL MEMBRANE DEPOLARIZATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; HUMAN; HYPERTHYROIDISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY VEIN; RADIOFREQUENCY ABLATION; REVIEW; VALVULAR HEART DISEASE; VEIN DIAMETER;

ANIMALS; ATRIAL FIBRILLATION; HEART CONDUCTION SYSTEM; HUMANS; PULMONARY VEINS; VASOCONSTRICTION;

EID: 70349106776     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2009.07.002     Document Type: Review

References (139)

1. Arentz T., Haegeli L., Sanders P., Weber R., Neumann F.J., Kalusche D., et al. High-density mapping of spontaneous pulmonary vein activity initiating atrial fibrillation in humans. J Cardiovasc Electrophysiol 18 (2007) 31-38
2. Armour J.A., Murphy D.A., Yuan B.X., Macdonald S., and Hopkins D.A. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec 247 (1997) 289-298
3. Arora R., Verheule S., Scott L., Navarrete A., Katari V., Wilson E., et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 107 (2003) 1816-1821
4. Atienza F., and Jalife J. Reentry and atrial fibrillation. Heart Rhythm 4 Suppl 3 (2007) S13-S16 2007
5. Atienza F., Almendral J., Moreno J., Vaidyanathan R., Talkachou A., Kalifa J., et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation 114 (2006) 2434-2442
6. Bertaglia E., Stabile G., Senatore G., Colella A., Del Greco M., Goessinger H., et al. A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study). Europace 9 (2007) 182-185
7. Bode F., Katchman A., Woosley R.L., and Franz M.R. Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation 101 (2000) 2200-2205
8. Bode F., Sachs F., and Franz M.R. Tarantula peptide inhibits atrial fibrillation. Nature 409 (2001) 35-36
9. CABANA, http://clinicaltrials.gov/ct2/show/record/NCT00578617?term=ablation+for+atrial+fibrillation&rank=20. Last accessed on Aug 31, 2008.
10. Cappato R., Calkins H., Chen S.A., Davies W., Iesaka Y., Kalman J., et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111 (2005) 1100-1105
11. Cech S. Adrenergic innervation of blood vessels in the lung of some mammals. Acta Anat 74 (1969) 169-182
12. Chang S.L., Chen Y.C., Chen Y.J., Wangcharoen W., Lee S.H., Lin C.I., et al. Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins. Heart 93 (2007) 82-88
13. 2+ stores potentially determine the spontaneous activity of pulmonary vein cardiomyocytes. Life Sci 83 (2008) 284-292
14. Chen Y.J., Chen S.A., Chang M.S., and Lin C.I. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res 48 (2000) 265-273
15. Chen Y.J., Chen S.A., Chen Y.C., Yeh H.I., Chan P., Chang M.S., et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: Implication in initiation of atrial fibrillation. Circulation 104 (2001) 2849-2854
16. Chen Y.J., Chen S.A., Chen Y.C., Yeh H.I., Chang M.S., and Lin C.I. Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation. Basic Res Cardiol 97 (2002) 26-34
17. Chen Y.C., Chen S.A., Chen Y.J., Chang M.S., Chan P., and Lin C.I. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol 39 (2002) 366-372
18. Chen Y.C., Chen S.A., Chen Y.J., Tai C.T., Chan P., and Lin C.I. T-type calcium current in electrical activity of cardiomyocytes isolated from rabbit pulmonary vein. J Cardiovasc Electrophysiol 15 (2004) 567-571
19. Chen Y.J., Chen Y.C., Tai C.T., Yeh H.I., Lin C.I., and Chen S.A. Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins. Br J Pharmacol 147 (2006) 12-22
20. Chen S.A., Hsieh M.H., Tai C.T., Tsai C.F., Prakash V.S., Yu W.C., et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100 (1999) 1879-1886
21. Chen Y.J., Chen Y.C., Wongcharoen W., Lin C.I., and Chen S.A. Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes. Br J Pharmacol 153 (2008) 915-925
22. Cheung D.W. Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea pig. J Physiol 314 (1981) 445-456
23. Cheung D.W. Pulmonary vein as an ectopic focus in digitalis-induced arrhythmia. Nature 294 (1981) 582-584
24. Chevalier P., Tabib A., Meyronnet D., Chalabreysse L., Restier L., Ludman V., et al. Quantitative study of nerves of the human left atrium. Heart Rhythm 2 (2005) 518-522
25. Chiu Y.T., Wu T.J., Wei H.J., Cheng C.C., Lin N.N., Chen Y.T., et al. Increased extracellular collagen matrix in myocardial sleeves of pulmonary veins: an additional mechanism facilitating repetitive rapid activities in chronic pacing-induced sustained atrial fibrillation. J Cardiovasc Electrophysiol 16 (2005) 753-759
26. Chou C.C., Nihei M., Zhou S., Tan A.Y., Kawase A., Macias E.S., et al. Intracellular calcium dynamics and anisotropic reentry in isolated canine pulmonary veins and left atrium. Circulation 111 (2005) 2889-2297
27. Chou C.C., Nguyen B.L., Tan A.Y., Chang P.C., Lee H.L., Lin F.C., et al. Intracellular calcium dynamics and acetylcholine-induced triggered activity in the pulmonary veins of dogs with pacing-induced heart failure. Heart Rhythm 5 (2008) 1170-1177
28. Chou C.C., Zhou S., Miyauchi Y., Pak H.N., Okuyama Y., Fishbein M.C., et al. Effects of procainamide on electrical activity in thoracic veins and atria in canine model of sustained atrial fibrillation. Am J Physiol 286 (2004) H1936-H1945
29. Dixit S., Gerstenfeld E.P., Callans D.J., and Marchlinski F.E. Mechanisms underlying sustained firing from pulmonary veins: evidence from pacing maneuvers and pharmacological manipulation. Pacing Clin Electrophysiol 27 (2004) 1120-1129
30. Ehrlich J.R., Cha T.J., Zhang L., Chartier D., Melnyk P., Hohnloser S.H., et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J Physiol 551 (2003) 801-813
31. El Bermani A.W., McNary W.F., and Bradley D.E. The distribution of acetylcholinesterase and catecholamine containing nerves in the rat lung. Anat Rec 167 (1970) 205-212
32. Fedida D. Vernakalant (RDS1235): a novel, atrial-selective antifibrillatory agent. Expert Opin Investig Drugs 16 (2007) 519-532
33. Fetsch T., Bauer P., Engberding R., Koch H.P., Lukl J., Meinertz T., et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25 (2004) 1385-1394
34. Fisher A.W.F. The intrinsic innervation of the pulmonary vessels. Acta Anat 60 (1965) 482-496
35. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation. J Am Coll Cardiol 48 (2006) 854-906
36. i in isolated guinea pig ventricular myocytes. Cardiovasc Res 28 (1994) 1193-1198
37. Gentile F., Mantero A., Lippolis A., Ornaghi M., Azzollini M., Barbier P., et al. Pulmonary venous flow velocity patterns in 143 normal subjects aged 20 to 80 years old. An echo 2D colour Doppler cooperative study. Eur Heart J 18 (1997) 148-164
38. Gjesdal K., Vist G.E., Bugge E., Rossvoll O., Johansen M., Norderhaug I., et al. Curative ablation for atrial fibrillation: a systematic review. Scand Cardiovasc J 42 (2008) 3-8
39. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375
40. Haissaguerre M., Jaïs P., Shah D.C., Takahashi A., Hocini M., Quiniou G., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
41. Haissaguerre M., Shah D.C., Jaïs P., Hocini M., Yamane T., Deisenhofer I., et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 102 (2000) 2463-2465
42. Hamabe A., Okuyama Y., Miyauchi Y., Zhou S., Pak H.N., Karagueuzian H.S., et al. Correlation between anatomy and electrical activation in canine pulmonary veins. Circulation 107 (2003) 1550-1555
43. Hassink R.J., Aretz H.T., Ruskin J., and Keane D. Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation. J Am Coll Cardiol 42 (2003) 1108-1114
44. Herweg B., Sichrovsky T., Polosajian L., Rozenshtein A., and Steinberg J.S. Hypertension and hypertensive heart disease are associated with increased ostial pulmonary vein diameter. J Cardiovasc Electrophysiol 16 (2005) 2-5
45. Hirose M., Ohkubo Y., Takano M., Hamazaki M., Sekido T., and Yamada M. Mechanisms of the preventive effect of pilsicainide on atrial fibrillation originating from the pulmonary vein. Circ J 71 (2007) 1805-1814
46. Ho S.Y., Cabrera J.A., Tran V.H., Farré J., Anderson R.H., and Sánchez-Quintana D. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart 86 (2001) 265-270
47. Ho S.Y., Sanchez-Quintana D., Cabrera J.A., and Anderson R.H. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 10 (1999) 1525-1533
48. Hocini M., Ho S.Y., Kawara T., Linnenbank A.C., Potse M., Shah D., et al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation 105 (2002) 2442-2448
49. Honjo H., Boyett M.R., Niwa R., Inada S., Yamamoto M., Mitsui K., et al. Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine. Circulation 107 (2003) 1937-1943
50. Iwasa, A., Okumura, K., Tabuchi, T., Tsuchiya, T., Tsunoda, R., Matsunaga, T., et al. (1998). Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: role of suppressant effect in conductivity. Eur J Pharmacol 356, 31-40.
51. Jaïs P., Hocini M., Macle L., Choi K.J., Deisenhofer I., Weerasooriya R., et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 106 (2002) 2479-2485
52. Jones W.K., Sanchez A., and Robbins J. Murine pulmonary myocardium: developmental analysis of cardiac gene expression. Dev Dyn 200 (1994) 117-128
53. Jones S.A., Yamamoto M., Tellez J.O., Billeter R., Boyett M.R., Honjo H., et al. Distinguishing properties of cells from the myocardial sleeves of the pulmonary veins: a comparison of normal and abnormal pacemakers. Circ Arrhythmia Electrophysiol 1 (2008) 39-48
54. Kalifa J., Jalife J., Zaitsev A.V., Bagwe S., Warren M., Moreno J., et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 108 (2003) 668-671
55. Kanagaratnam P., Cherian A., Stanbridge R.D., Glenville B., Severs N.J., and Peters N.S. Relationship between connexins and atrial activation during human atrial fibrillation. J Cardiovasc Electrophysiol 15 (2004) 206-216
56. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306 (1982) 1018-1022
57. Kholová I., and Kautzner J. Anatomic characteristics of extensions of atrial myocardium into the pulmonary veins in subjects with and without atrial fibrillation. Pacing Clin Electrophysiol 26 (2003) 1348-1355
58. Klavins J.V. Demonstration of striated muscle in the pulmonary veins of the rat. J Anat 97 (1963) 239-241
59. Knackstedt C., Visser L., Plisiene J., Zarse M., Waldmann M., Mischke K., et al. Dilatation of the pulmonary veins in atrial fibrillation: a transesophageal echocardiographic evaluation. Pacing Clin Electrophysiol 26 (2003) 1371-1378
60. Kostin S., Klein G., Szalay Z., Hein S., Bauer E.P., and Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54 (2002) 361-379
61. Kramer A.W., and Marks L.S. The occurrence of cardiac muscle in the pulmonary veins of Rodentia. J Morph 117 (1965) 135-150
62. Krittayaphong R., Raungrattanaamporn O., Bhuripanyo K., Sriratanasathavorn C., Pooranawattanakul S., Punlee K., et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai 86 Suppl 1 (2003) S8-S16
63. Kumagai K., Ogawa M., Noguchi H., Yasuda T., Nakashima H., and Saku K. Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. J Am Coll Cardiol 43 (2004) 2281-2289
64. + channel blocker pilsicainide on the electrophysiologic properties of pulmonary veins in patients with atrial fibrillation. J Cardiovasc Electrophysiol 15 (2004) 1396-1401
65. Li D., Zhang L., and Nattel S. Potential ionic mechanism for repolarization differences between canine right and left atrium. Circ Res 88 (2001) 1168-1175
66. Lin W.S., Prakash V.S., Tai C.T., Hsieh M.H., Tsai C.F., Yu W.C., et al. Pulmonary vein morphology in patients with paroxysmal atrial fibrillation initiated by ectopic beats originating from the pulmonary veins: implications for catheter ablation. Circulation 101 (2000) 1274-1281
67. Lindgren K.S., Pekka Raatikainen M.J., Juhani Airaksinen K.E., and Huikuri H.V. Relationship between the frequency of paroxysmal episodes of atrial fibrillation and pulmonary venous flow pattern. Europace 5 (2003) 17-23
68. Lo L.W., Chen Y.C., Chen Y.J., Wongcharoen W., Lin C.I., and Chen S.A. Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins. Eur J Pharmacol 571 (2007) 197-208
69. Ludatscher R.M. Fine structure of the muscular wall of rat pulmonary veins. J Anat 103 (1968) 345-357
70. Lutomsky B.A., Rostock T., Koops A., Steven D., Müllerleile K., Servatius H., et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace 10 (2008) 593-599
71. Lyons G.E., Schiaffino S., Sassoon D., Barton P., and Buckingham M.E. Developmental regulation of myosin expression in mouse cardiac muscle. J Cell Biol 111 (1990) 2427-2437
72. Ma C.S., Liu X., Hu F.L., Dong J.Z., Liu X.P., Wang X.H., et al. Catheter ablation of atrial fibrillation in patients with hyperthyroidism. J Interv Card Electrophysiol 18 (2007) 137-142
73. Maruyama T., Kishikawa T., Ito H., Kaji Y., Sasaki Y., and Ishihara Y. Augmentation of pulmonary vein backflow velocity during left atrial contraction: a novel phenomenon responsible for progression of atrial fibrillation in hypertensive patients. Cardiology 109 (2008) 33-40
74. Masani F. Node-like cells in the myocardial layer of the pulmonary vein of rats: an ultrastructural study. J Anat 145 (1986) 133-142
75. Mathew J., Hunsberger S., Fleg J., McSherry F., Williford W., and Yusuf S. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 118 (2000) 914-922
76. 1-adrenoceptors. Br J Pharmacol 150 (2007) 899-905
77. Melnyk P., Ehrlich J.R., Pourrier M., Villeneuve L., Cha T.J., and Nattel S. Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium. Cardiovasc Res 65 (2005) 104-116
78. Melo J.Q., Benussi S., Tortoriello W., Santinelli V., Calvi S., Nascimbene S., et al. Origin of atrial fibrillation from the pulmonary veins in a mitral patient. J Thorac Cardiovasc Surg 126 (2003) 914-916
79. Millino C., Sarinella F., Tiveron C., Villa A., Sartore S., and Ausoni S. Cardiac and smooth muscle cell contribution to the formation of the murine pulmonary veins. Dev Dyn 218 (2000) 414-425
80. Miyauchi Y., Hayashi H., Miyauchi M., Okuyama Y., Mandel W.J., Chen P.S., et al. Heterogeneous pulmonary vein myocardial cell repolarization implications for reentry and triggered activity. Heart Rhythm 2 (2005) 1339-1345
81. Mommersteeg M.T., Brown N.A., Prall O.W., de Gier-de Vries C., Harvey R.P., Moorman A.F., et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 101 (2007) 902-909
82. Moubarak J.B., Rozwadowski J.V., Strzalka C.T., Buck W.R., Tan W.S., Kish G.F., et al. Pulmonary veins-left atrial junction: anatomic and histological study. Pacing Clin Electrophysiol 23 (2000) 1836-1838
83. Mueller-Hoecker J., Beitinger F., Fernandez B., Bahlmann O., Assmann G., Troidl C., et al. Of rodents and humans: a light microscopic and ultrastructural study on cardiomyocytes in pulmonary veins. Int J Med Sci 5 (2008) 152-158
84. Nao T., Ohkusa T., Hisamatsu Y., Inoue N., Matsumoto T., Yamada J., et al. Comparison of expression of connexin in right myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol 91 (2003) 678-683
85. Nathan H., and Eliakim M. The junction between the left atrium and the pulmonary veins: an anatomic study of human hearts. Circulation 34 (1966) 412-422
86. Nathan H., and Gloobe H. Myocardial atrio-venous junctions and extensions (sleeves) over the pulmonary and caval veins. Anatomical observations in various mammals. Thorax 25 (1970) 317-324
87. Okuyama Y., Miyauchi Y., Park A.M., Hamabe A., Zhou S., Hayashi H., et al. High resolution mapping of the pulmonary vein and the vein of Marshall during induced atrial fibrillation and atrial tachycardia in a canine model of pacing-induced congestive heart failure. J Am Coll Cardiol 42 (2003) 348-360
88. Oral H., Knight B.P., Tada H., Ozaydin M., Chugh A., Hassan S., et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 105 (2002) 1077-1081
89. Oral H., Pappone C., Chugh A., Good E., Bogun F., Pelosi Jr. F., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 354 (2006) 934-941
90. Paes de Almeida O., Bohm C.M., de Paula Carvalho M., and Paes de Carvalho A. The cardiac muscle in the pulmonary vein of the rat: a morphological and electrophysiological study. J Morphol 145 (1975) 409-433
91. Pan N.H., Tsao H.M., Chang N.C., Chen Y.J., and Chen S.A. Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation. Chest 133 (2008) 190-196
92. Pappone C., Augello G., Sala S., Gugliotta F., Vicedomini G., Gulletta S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 48 (2006) 2340-2347
93. Parambil J.G., Gersh B.J., Knight M.Z., Krowka M.J., and Ryu J.H. Bronchogenic cyst causing atrial fibrillation by impinging the right inferior pulmonary vein. Am J Med Sci 331 (2006) 336-338
94. Patten M., Maas R., Bauer P., Lüderitz B., Sonntag F., Dluzniewski M., et al. Suppression of paroxysmal atrial tachyarrhythmias-results of the SOPAT trail. Eur Heart J 25 (2004) 1395-1404
95. 2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol 47 (2006) 1196-1206
96. Patterson E., Po S.S., Scherlag B.J., and Lazzara R. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2 (2005) 624-631
97. Pauza D.H., Skripka V., Pauziene N., and Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 259 (2000) 353-382
98. Perez-Lugones A., McMahon J.T., Ratliff N.B., Saliba W.I., Schweikert R.A., Marrouche N.F., et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol 14 (2003) 803-809
99. Po S.S., Li Y., Tang D., Liu H., Geng N., Jackman W.M., et al. Rapid and stable re-entry within the pulmonary vein as a mechanism initiating paroxysmal atrial fibrillation. J Am Coll Cardiol 45 (2005) 1871-1877
100. Po S.S., Scherlag B.J., Yamanashi W.S., Edwards J., Zhou J., Wu R., et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm 3 (2006) 201-208
101. Policard A., and Pregermain S. La gaine myocardique des veines intrapulmonaires etudiee chez le rat au microscope electronique. Bull Microsc Appl 9 (1959) 5-9
102. Polontchouk L., Haefliger J.A., Ebelt B., Schaefer T., Stuhlmann D., Mehlhorn U., et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38 (2001) 883-891
103. RAAFT-2: http://clinicaltrials.gov/ct2/show/NCT00392054?term=RAAFT&rank=1. Last accessed on August 31, 2008.
104. Robbins I.M., Colvin E.V., Doyle T.P., Kemp W.E., Loyd J.E., McMahon W.S., et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 98 (1998) 1769-1775
105. Rostock T., Servatius H., Risius T., Ventura R., Weiss C., Meinertz T., et al. Impact of amiodarone on electrophysiologic properties of pulmonary veins in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 16 (2005) 39-44
106. Rostock T., Steven D., Lutomsky B., Servatius H., Drewitz I., Klemm H., et al. Atrial fibrillation begets atrial fibrillation in the pulmonary veins: on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans. J Am Coll Cardiol 51 (2008) 2153-2160
107. Roux N., Havet E., and Mertl P. The myocardial sleeves of the pulmonary veins: potential implications for atrial fibrillation. Surg Radiol Anat 26 (2004) 285-289
108. Ryu K., Shroff S.C., Sahadevan J., Martovitz N.L., Khrestian C.M., and Stambler B.S. Mapping of atrial activation during sustained atrial fibrillation in dogs with rapid ventricular pacing induced heart failure: evidence for a role of driver regions. J Cardiovasc Electrophysiol 16 (2005) 1348-1358
109. Saad E.B., Marrouche N.F., Saad C.P., Ha E., Bash D., White R.D., et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann Intern Med 138 (2003) 634-638
110. Saito T., Waki K., and Becker A.E. Left atrial myocardial extension onto pulmonary veins in humans: anatomic observations relevant for atrial arrhythmias. J Cardiovasc Electrophysiol 11 (2000) 888-894
111. Sakai R., Inoue D., Ishibashi K., Inoue M., Shirayama T., Yamahara Y., et al. Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium. J Cardiovasc Pharmacol 25 (1995) 953-960
112. Schauerte P., Scherlag B.J., Patterson E., Scherlag M.A., Matsudaria K., Nakagawa H., et al. Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system. J Cardiovasc Electrophysiol 12 (2001) 592-599
113. Scherlag B.J., Yamanshi W., Patel U., Lazzara R., and Jackman W.M. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol 7 (2005) 1878-1886
114. Seol C.A., Kim W.T., Ha J.M., Choe H., Jang Y.J., Youm J.B., et al. Stretch-activated currents in cardiomyocytes isolated from rabbit pulmonary veins. Prog Biophys Mol Biol 97 (2008) 217-231
115. Sicouri S., Glass A., Belardinelli L., and Antzelevitch C. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations. Heart Rhythm 5 (2008) 1019-1026
116. Stabile G., Bertaglia E., Senatore G., De Simone A., Zoppo F., Donnici G., et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 27 (2006) 216-221
117. Steiner I., Hájková P., Kvasnicka J., and Kholová I. Myocardial sleeves of pulmonary veins and atrial fibrillation: a postmortem histopathological study of 100 subjects. Virchows Arch 449 (2006) 88-95
118. Sun Q., Tang M., Pu J., and Zhang S. Pulmonary venous structural remodeling in a canine model of chronic atrial dilation due to mitral regurgitation. Can J Cardiol 24 (2003) 305-308
119. Tabata T., Thomas J.D., and Klein A.L. Pulmonary venous flow by Doppler echocardiography: revisited 12 years later. J Am Coll Cardiol 41 (2003) 1243-1250
120. Tagawa M., Higuchi K., Chinushi M., Washizuka T., Ushiki T., Ishihara N., et al. Myocardium extending from the left atrium onto the pulmonary veins. Pacing Clin Electrophysiol. 24 (2001) 1459-1463
121. Takahashi Y., Iesaka Y., Takahashi A., Goya M., Kobayashi K., Fujiwara H., et al. Reentrant tachycardia in pulmonary veins of patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 14 (2003) 927-932
122. Tan A.Y., Li H., Wachsmann-Hogiu S., Chen L.S., Chen P.S., and Fishbein M.C. Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction. J Am Coll Cardiol 48 (2006) 132-143
123. Tan A.Y., Zhou S., Jung B.C., Ogawa M., Chen L.S., Fishbein M.C., et al. Ectopic atrial arrhythmias arising from canine thoracic veins during in-vivo stellate ganglia stimulation. Am J Physiol Heart Circ Physiol 259 (2008) H691-H698
124. Tojo H., Kumagai K., Noguchi H., Ogawa M., Yasuda T., Nakashima H., et al. Hybrid therapy with pilsicainide and pulmonary vein isolation for atrial fibrillation. Circ J 69 (2005) 1503-1507
125. Tondo C., Mantica M., Russo G., Avella A., De Luca L., Pappalardo A., et al. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol 29 (2006) 962-970
126. Tsao H.M., Yu W.C., Cheng H.C., et al. Pulmonary vein dilation in patients with atrial fibrillation: detection by magnetic resonance imaging. J Cardiovasc Electrophysiol 12 (2001) 809-813
127. Turco P., De Simone A., La Rocca V., Iuliano A., Capuano V., Astarita C., et al. Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation. Pacing Clin Electrophysiol 30 Suppl 1 (2007) S112-S115
128. Vaitkevicius R., Saburkina I., Zaliunas R., Pauziene N., Vaitkeviciene I., Schauerte P., et al. Innervation of pulmonary veins: morphologic pattern and pathways of nerves in the human fetus. Ann Anat 190 (2008) 158-166
129. van den Hoff M.J., Kruithof B.P., and Moorman A.F. Making more heart muscle. Bioessays 26 (2004) 248-261
130. Verheule S., Wilson E.E., Arora R., Engle S.K., Scott L.R., and Olgin J.E. Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc Res 55 (2002) 727-738
131. Wang T., Chiang C.E., Sheu J., Tsou C., Chang H., and Luk H. Homogenous distribution of fast response action potentials in canine pulmonary vein sleeves: a contradictory report. Int J Cardiol 89 (2003) 187-195
132. Wang T.M., Luk H.N., Sheu J.R., Wu H.P., and Chiang C.E. Inducibility of abnormal automaticity and triggered activity in myocardial sleeves of canine pulmonary veins. Int J Cardiol 104 (2005) 59-66
133. Wazni O.M., Marrouche N.F., Martin D.O., Verma A., Bhargava M., Saliba W., et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293 (2005) 2634-2640
134. Wetzel U., Boldt A., Lauschke J., Weigl J., Schirdewahn P., Dorszewski A., et al. Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart 91 (2005) 166-170
135. Yamada T., Murakami Y., Okada T., Yoshida N., Toyama J., Yoshida Y., et al. Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation. Int Heart J 49 (2008) 143-151
136. Yamamoto M., Dobrzynski H., Tellez J., Niwa R., Billeter R., Honjo H., et al. Extended atrial conduction system characterised by the expression of the HCN4 channel and connexion 45. Cardiovasc Res 72 (2006) 271-281
137. Yamane T., Shah D.C., Jaïs P., Hocini M., Peng J.T., Deisenhofer I., et al. Dilatation as a marker of pulmonary veins initiating atrial fibrillation. J Interv Card Electrophysiol 6 (2002) 245-249
138. Yu W.C., Hsu T.L., Tai C.T., Tsai C.F., Hsieh M.H., Lin W.S., et al. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 12 (2001) 887-892
139. Zhou S., Chang C.M., Wu T.J., Miyauchi Y., Okuyama Y., Park A.M., et al. Nonreentrant focal activations in pulmonary veins in canine model of sustained atrial fibrillation. Am J Physiol 283 (2002) H1244-H1252